ISRAEL EXPORT INSTITUTE

Visit of senior representative from Debiopharm Innovation Fund

27

June
2019
Full Dates
27
June
Thursday

Type

Business Meetings

Sectors

Medical Device & Digital Health

Event Code

9153

Location

IEI Offices, Hamered 29, Tel Aviv

Contact us for more details and prices

More Information

Visit of senior representative from Debiopharm Innovation Fund

Expand All

Visit of senior representative from Debiopharm Innovation Fund

+

On June 27th we will host at IEI senior representative from Debiopharm Innovation Fund , a sister company of Debiopharm Group which is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. Active in the life science areas of drug development, GMP manufacturing of proprietary drugs and diagnostic tools. 420 employees.

 

Debiopharm Innovation Fund's objective is to make strategic investments in innovative companies with technologies and business models that change the they develop drugs and treat patients. 


Senior representatives from Debiopharm Innovation Fund will be having B2B meetings with several Israeli digital health companies in the field of Oncology and Infectious Disease to explore ways of cooperation and investment opportunities.

Contact us

I confirm receipt of direct mail from the Export Institute
FullNameNotTyped PhoneNotTyped SubjectNotSelected

Thank You!

טעינה

Event Of the Week